drugset
drugset / Trial / NCT03494205

Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis

NCT03494205 ↗

Phase 2 Completed 31 enrolled University of Bern
RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized controlled trial comparing Urtica comp. gel (Swissmedic listed medication in the category of "Anthroposophic Medication without Indication") against standard skin care, examining its effect in prevention and treatment of radiation dermatitis in breast cancer patients under Radiation therapy.

Timeline

Start
2018-05-02
Primary completion
2022-02-10
Completion
2022-02-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Excipial-Hydrolotion Unknown — —
Subject Urtica comp. gel Other / unclassified — Topical

Indications

radiodermatitis